BRG1 expression is increased in human cutaneous melanoma

H Lin1, R P C Wong, M Martinka

  • 1Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC, Canada.

Abstract

Insights

BRG1 expression increases in melanoma, driving cancer initiation. Reducing BRG1 in melanoma cells inhibits proliferation by arresting the cell cycle.

Area of Science:

  • Oncology
  • Cell Biology
  • Chromatin Remodeling

Background:

  • The SWI/SNF chromatin remodelling complex is crucial for cellular processes and its aberrant expression is linked to cancer.
  • While SNF5 is a known tumor suppressor, the role of the catalytic subunit BRG1 in cancer remains unclear.

Purpose of the Study:

  • To investigate the role of BRG1 in melanoma development.
  • To analyze BRG1 expression in melanocytic lesions and its correlation with clinicopathological variables and patient survival.

Main Methods:

  • Tissue microarray and immunohistochemistry were used to evaluate BRG1 expression in dysplastic naevi, primary melanomas, and metastatic melanomas.
  • Small interfering RNA was employed to reduce BRG1 expression in melanoma cell lines, followed by cell proliferation and cell cycle assays.

Main Results:

  • BRG1 expression was significantly elevated in primary and metastatic melanomas compared to dysplastic naevi.
  • BRG1 knockdown in melanoma cells led to reduced proliferation due to G1 phase arrest, with downregulation of cyclin D1.
  • No significant correlation was found between BRG1 expression and melanoma patient survival.

Conclusions:

  • BRG1 is significantly upregulated in human melanoma.
  • Increased BRG1 expression is implicated in melanoma initiation and progression.
  • BRG1 plays a role in regulating melanoma cell proliferation.